>> THE RACE FOR A COVID VACCINE 
IS UNLIKE ANY OTHER PANDEMIC IN 
RECENT HISTORY.
IT TOOK EIGHT YEARS FOR AN 
EFFECTIVE EBOLA VACCINE.
SIX MONTHS FOR A SAFE H1N1 
VACCINE.
AND IT IS POSSIBLE A COVID 
VACCINE WON'T BE MUCH LONGER.
WE'RE NOT COMPARING APPLES TO 
APPLES.
DECADES OF RESEARCH MADE THE 
HNLHAN POSSIBLE.
A LUXURY SCIENTISTS DON'T HAVE 
NOW.
>> ONE THING I SAY IS EXPECT THE
UNEXPECTED.
WHEN YOU'RE STARTING SOMETHING 
NEW IN VACCINE DEVELOPMENT, 
THINGS WILL OCCUR.
>> DR. JESSE GOODMAN IS AN 
INFECTIOUS DISEASE PROFESSOR AT 
GEORGETOWN UNIVERSITY.
HE FORMALLY SERVED AS THE CHIEF 
SCIENTIST WHERE HE LED.
>> THIS IS A BIGGER CHALLENGE 
THAN WE HAD IN 2009.
WE COULD BUILD ON PROVEN 
VACCINES WHERE WE HAD PRETTY 
HIGH CONFIDENCE IN MANUFACTURING
QUALITY AND IN THEIR SAFETY AND 
IN THEIR PERFORMANCE.
>> YET THERE ISN'T HIGH 
CONFIDENCE IN VACCINE 
DEVELOPMENT FOR THE CORONAVIRUS 
FAMILY.
SCIENTISTS HAVE STRUGGLED TO 
PRODUCE QUALITY ANTIBODIES FOR 
OTHER STRAINS.
IN FACT ANIMAL MODELS SHOWED IT 
MADE THE DISEASE WORSE.
>> THAT'S A POTENTIAL SAFETY 
CONCERN.
THAT THESE VACCINES PROTECT AND 
DON'T HAVE THIS THEORETICAL RISK
OF MAKING THE DISEASE WORSE.
>> SINCE YOU'VE BEEN THROUGH 
THIS BEFORE, WHAT ARE YOU MOST 
CONCERNED ABOUT?
>> EVEN THOUGH THERE HASN'T BEEN
A HINT OF IT YET.
COULD THERE BE MUCH RARER, MORE 
SERIOUS SIDE EFFECTS.
>> IT IS THOSE QUESTIONS THAT 
POINT TO THE FDA'S VACCINE 
MONITORING PROCESS.
A TEAM GOODMAN LED FOR FIVE 
YEARS.
>> THE PUBLIC IS REHIGHING ON 
THAT PROCESS NOT ONLY BEING 
THOROUGH BUT TRANSPARENT.
FROM YOUR PERSPECTIVE, WHAT 
SHOULD BE PUBLIC?
>> SO I THINK THE DATA ON SAFETY
AND EFFECTIVENESS THAT COMES OUT
OF THESE TRIALS SHOULD BE, YOU 
KNOW, FULLY AVAILABLE.
EVERYTHING YOU WANT TO KNOW 
ABOUT AVERSE EVENTS.
WHERE WE DON'T HAVE ALL THE DATA
IN YET, IF THERE WAS AN 
EMERGENCY, IT SHOULD BE CLEAR 
WHAT THE GAPS ARE.
>> IF THERE ARE GAPS, AMERICANS 
DESERVE TO KNOW THERE WERE NO 
SHORTCUTS TO COMPROMISED SAFETY.
>> ONCE A COVID VACCINE IS 
APPROVED AND IN USE ACROSS THE 
COUNTRY, THE FDA AND CDC WILL 
CONTINUE TO MONITOR SAFETY AND 
ANY POTENTIAL SIDE EFFECTS 
THROUGH A FEDERA
